Earnings calendar/PBYI
PUMA BIOTECHNOLOGY, INC. (PBYI)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Latest EPS YoY
+26.7%
vs 2025-08-07
Latest revenue YoY
+7.8%
How results look so far
Trailing revenue (avg 4Q)
$53.9M
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS beat
EPS actual / est
$0.19 / $0.04
+375.0%
Revenue actual / est
$56.5M / $53.0M
+6.6%
Result
Target reached
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 8/6/2026 | $0.04 | $0.19 | +375.0% | $53.0M | $56.5M | +6.6% |
| 5/14/2026upcoming | $-0.13 | Pending | — | $42.0M | Pending | — |
| 5/7/2026 | $-0.13 | $-0.04 | +69.2% | $42.0M | $44.8M | +6.7% |
| 2/26/2026 | $0.24 | $0.29 | +20.8% | $68.6M | $59.9M | -12.7% |
| 11/6/2025 | $0.09 | $0.21 | +133.3% | $68.6M | $54.5M | -20.6% |
| 8/7/2025 | $0.11 | $0.15 | +36.4% | $51.0M | $52.4M | +2.8% |
| 5/8/2025 | $0.02 | $0.10 | +400.0% | $52.8M | $46.0M | -12.8% |
| 2/27/2025 | $0.10 | $0.43 | +330.0% | $52.5M | $59.1M | +12.5% |
| 11/7/2024 | $0.35 | $0.41 | +17.1% | $52.5M | $80.5M | +53.4% |
| 8/1/2024 | $-0.10 | $-0.05 | +50.0% | $44.7M | $47.1M | +5.3% |
| 5/2/2024 | $-0.16 | $-0.05 | +68.8% | $41.0M | $43.8M | +6.6% |
| 2/29/2024 | $0.30 | $0.26 | -13.3% | $73.5M | $72.2M | -1.9% |
| 11/2/2023 | $0.08 | $0.12 | +50.0% | $73.5M | $56.1M | -23.7% |
| 8/3/2023 | $0.07 | $0.10 | +42.9% | $51.7M | $54.6M | +5.5% |
| 5/4/2023 | $0.04 | $0.09 | +142.6% | $49.6M | $52.8M | +6.3% |
| 3/2/2023 | $0.06 | $-0.12 | -300.0% | $57.1M | $65.7M | +15.1% |
| 11/3/2022 | $-0.11 | $-0.01 | +90.9% | $50.5M | $57.1M | +13.1% |
| 8/4/2022 | $0.00 | $0.21 | +13900.0% | $52.6M | $59.5M | +13.1% |
| 5/5/2022 | $-0.13 | $-0.08 | +38.5% | $45.1M | $45.7M | +1.5% |
| 3/3/2022 | $-0.09 | $0.10 | +211.1% | $47.2M | $55.4M | +17.5% |
Need PBYI data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.